Urologic Conditions

Benign prostatic hyperplasia (BPH) or enlarged prostate is noncancerous condition caused by hormonal changes later in life.

Most often, this cancer begins in the cells on the surface of the inner lining of the bladder.

Treatment is based on the underlying medical issue causing the problem.

Cancer forms when some kidney cells acquire mutations in their DNA. Renal cell carcinoma is the most common type of kidney cancer.

These are hard deposits of minerals that are clumped together and formed in the urinary tract or kidney.

Cancer that occurs in the prostate, and mostly develops from gland cells.

Cancers develops in germ cells and non-germ cells of the testicle.

Begins in cells that line the inside of the tubes (ureters) that connect your kidneys to your bladder.

Begins in cells that line the inside of the tubes (ureters) that connect your kidneys to your bladder.

Poor coordination between the bladder muscle and the urethra.

Active surveillance allows the oncologist to assess the progress of the disease, which may guide treatment recommendations.

Aquablation Therapy provides the urologic oncologist more treatment options for Benign Prostatic Hyperplasia (BPH)/Enlarged Prostate.

HIFU provides the urologic oncologist more treatment options for prostate cancer.

Radiotherapy (or radiation therapy) works by disrupting the DNA of rapidly growing cancer cells.

Robotic surgery offers improved visualization and surgical control of delicate procedures, which allows for a more precise surgery and faster patient recovery.

Robotic offers improved outcomes for treating ureteral obstructions and surgical reconstruction.

Surgery is recommended to reduce or eliminate the ongoing risk of cancerous tumors by safely removing as much of the affected tissues as possible.